Books, Original Papers & Review Papers- TAKANO Tadao -
number of results to view: what to display: sort:
[B]:Books [O]:Original Papers [R]:Review Papers
total:263
[2020]
1.[O] Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology..[International journal of clinical oncology,25(3),(2020),403-417]Yoichi Naito, Saori Mishima, Kiwamu Akagi, Ataru Igarashi, Masafumi Ikeda, Susumu Okano, Shunsuke Kato, Tadao Takano, Katsuya Tsuchihara, Keita Terashima, Hiroshi Nishihara, Hiroyki Nishiyama, Eiso Hiyama, Akira Hirasawa, Hajime Hosoi, Osamu Maeda, Yasushi Yatabe, Wataru Okamoto, Shigeru Ono, Hiroaki Kajiyama, Fumio Nagashima, Yutaka Hatanaka, Mitsuru Miyachi, Yasuhiro Kodera, Takayuki Yoshino, Hiroya Taniguchi
10.1007/s10147-019-01610-y
http://www.ncbi.nlm.nih.gov/pubmed/31974683
[2019]
2.[O] A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)..[International journal of clinical oncology,24(10),(2019),1284-1291]Fujiwara H, Ushijima K, Nagao S, Takei Y, Shimada M, Takano M, Yoshino K, Kawano Y, Hirashima Y, Nagase S, Nishio S, Nishikawa T, Ito K, Shoji T, Kimura E, Takano T, Sugiyama T, Kigawa J, Fujiwara K, Suzuki M
10.1007/s10147-019-01471-5
http://www.ncbi.nlm.nih.gov/pubmed/31127479
3.[O] An overview of ethical review committees in Japan: examining the certification applications of ethical review committees..[Nagoya journal of medical science,81(3),(2019),501-509]Iijima Y, Ogasawara K, Toda S, Takano T
10.18999/nagjms.81.3.501
http://www.ncbi.nlm.nih.gov/pubmed/31579340
4.[O] Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition..[International journal of clinical oncology,(2019)]Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T
10.1007/s10147-019-01498-8
http://www.ncbi.nlm.nih.gov/pubmed/31286289
5.[O] Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years..[Surgical oncology,29,(2019),25-32]Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD
10.1016/j.suronc.2019.02.002
http://www.ncbi.nlm.nih.gov/pubmed/31196490
6.[O] A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m<sup>2</sup> cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors..[International journal of clinical oncology,24(5),(2019),575-582]Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T
10.1007/s10147-018-01380-z
http://www.ncbi.nlm.nih.gov/pubmed/30580379
[2018]
7.[O] Clinical utility of CA-125 in the management of uterine carcinosarcoma..[Journal of gynecologic oncology,29(6),(2018),e88-]Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD
10.3802/jgo.2018.29.e88
http://www.ncbi.nlm.nih.gov/pubmed/30207096
8.[O] Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma..[Annals of surgical oncology,25(12),(2018),3676-3684]Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD
10.1245/s10434-018-6695-z
http://www.ncbi.nlm.nih.gov/pubmed/30105438
9.[O] Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element..[Surgical oncology,27(3),(2018),433-440]Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD
10.1016/j.suronc.2018.05.017
http://www.ncbi.nlm.nih.gov/pubmed/30217299
10.[O] Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma..[Annals of surgical oncology,25(9),(2018),2756-2766]Matsuo K, Takazawa Y, Ross MS, Elishaev E, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Yanai S, Takeuchi S, Nishimura M, Iwasaki K, Johnson MS, Yoshida M, Hakam A, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Kajiwara H, Hasegawa K, Yasuda M, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Pejovic T, Nagano T, Sasaki T, Richmond AM, Post MD, Shahzad MMK, Im DD, Yoshida H, Enomoto T, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD
10.1245/s10434-018-6547-x
http://www.ncbi.nlm.nih.gov/pubmed/29971677
11.[R] 臨床研究法 医学研究者/認定臨床研究審査委員会/研究実施管理者の視点から.[医事法学,33, (2018), 87-88]高野 忠夫
12.[O] Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery..[Journal of surgical oncology,117(3),(2018),488-496]Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman LD
10.1002/jso.24861
http://www.ncbi.nlm.nih.gov/pubmed/29044542
13.[O] Significance of venous thromboembolism in women with uterine carcinosarcoma..[Gynecologic oncology,148(2),(2018),267-274]Matsuo K, Ross MS, Im DD, Klobocista MM, Bush SH, Johnson MS, Takano T, Blake EA, Ikeda Y, Nishimura M, Ueda Y, Shida M, Hasegawa K, Baba T, Adachi S, Yokoyama T, Satoh S, Machida H, Yanai S, Iwasaki K, Miyake TM, Takeuchi S, Takekuma M, Nagano T, Yunokawa M, Pejovic T, Omatsu K, Shahzad MMK, Kelley JL, Ueland FR, Roman LD
10.1016/j.ygyno.2017.11.036
http://www.ncbi.nlm.nih.gov/pubmed/29248197
14.[O] Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study..[International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,28(1),(2018),2-10]Kim JW, Mahner S, Wu LY, Shoji T, Kim BG, Zhu JQ, Takano T, Park SY, Kong BH, Wu Q, Wang KL, Ngan HY, Liu JH, Wei LH, Mitrica I, Zhang P, Crescenzo R, Wang Q, Cox CJ, Harter P, du Bois A
10.1097/IGC.0000000000000602
http://www.ncbi.nlm.nih.gov/pubmed/26588236
[2017]
15.[O] Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.[GYNECOLOGIC ONCOLOGY,147(3),(2017),565-571]Koji Matsuo, Malcolm S. Ross, Mayu Yunokawa, Marian S. Johnson, Hiroko Machida, Kohei Omatsu, Merieme M. Klobocista, Dwight D. Im, Shinya Satoh, Tsukasa Baba, Yuji Ikeda, Stephen H. Bush, Kosei Hasegawa, Erin A. Blake, Munetaka Takekuma, Masako Shida, Masako Nishimura, Sosuke Adachi, Tanja Pejovic, Satoshi Takeuchi, Takuhei Yokoyama, Yutaka Ueda, Keita Iwasaki, Takahito M. Miyake, Shiori Yanai, Tadayoshi Nagano, Tadao Takano, Mian M. K. Shahzad, Frederick R. Ueland, Joseph L. Kelley, Lynda D. Roman
10.1016/j.ygyno.2017.10.008
http://www.ncbi.nlm.nih.gov/pubmed/29056442 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000418208700014&DestApp=WOS
16.[R] 【最新!婦人科がん薬物療法-化学療法薬から分子標的薬・免疫療法薬まで】子宮体がん 子宮肉腫に対する化学療法.[臨床婦人科産科,71(10), (2017), 992-1001]高野 忠夫
17.[O] Phase I study of nivolumab combined with IFN-beta for patients with advanced melanoma.[ONCOTARGET,8(41),(2017),71181-71187]Taku Fujimura, Takanori Hidaka, Yumi Kambayashi, Sadanori Furudate, Aya Kakizaki, Hisayuki Tono, Akira Tsukada, Takahiro Haga, Akira Hashimoto, Ryo Morimoto, Takuhiro Yamaguchi, Tadao Takano, Setsuya Aiba
10.18632/oncotarget.17090
http://www.ncbi.nlm.nih.gov/pubmed/29050354 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000411153300160&DestApp=WOS
18.[O] A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).[CANCER CHEMOTHERAPY AND PHARMACOLOGY,80(2),(2017),355-361]Tadahiro Shoji, Eriko Takatori, Hideo Omi, Masahiro Kagabu, Tatsuya Honda, Masayuki Futagami, Yoshihito Yokoyama, Michiko Kaiho, Hideki Tokunaga, Takeo Otsuki, Tadao Takano, Nobuo Yaegashi, Takanobu Kojimahara, Tsuyoshi Ohta, Satoru Nagase, Shu Soeda, Takafumi Watanebe, Hiroshi Nishiyama, Toru Sugiyama
10.1007/s00280-017-3363-0
http://www.ncbi.nlm.nih.gov/pubmed/28656383 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000406638200013&DestApp=WOS
19.[R] 当院における悪性軟部腫瘍に対する新規治療薬の使用.[日本婦人科腫瘍学会雑誌,35(3), (2017), 541]大山 喜子, 工藤 敬, 土岐 麻実, 渋谷 祐介, 櫻田 尚子, 橋本 千明, 永井 智之, 海法 道子, 徳永 英樹, 豊島 将文, 高野 忠夫, 島田 宗昭, 新倉 仁, 伊藤 潔, 八重樫 伸生
20.[R] 婦人科領域における稀少がん 卵巣原発と考えられた平滑筋肉腫の1例.[日本婦人科腫瘍学会雑誌,35(3), (2017), 453]工藤 敬, 徳永 英樹, 新倉 仁, 大山 喜子, 土岐 麻実, 渋谷 祐介, 櫻田 尚子, 橋本 千明, 永井 智之, 海法 道子, 豊島 将文, 高野 忠夫, 伊藤 潔, 八重樫 伸生
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [next]
BackTop
copyright(c)2005 Tohoku University